Derek M Meisner - Net Worth and Insider Trading

Derek M Meisner Net Worth

The estimated net worth of Derek M Meisner is at least $365,406 dollars as of 2024-11-05. Derek M Meisner is the Chief Legal Officer & Corp Sec of Acumen Pharmaceuticals Inc and owns about 108,867 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $326,601. Derek M Meisner is also the General Counsel of X4 Pharmaceuticals Inc and owns about 72,730 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $38,805. Details can be seen in Derek M Meisner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Derek M Meisner has not made any transactions after 2024-01-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Derek M Meisner

To

Derek M Meisner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Derek M Meisner owns 4 companies in total, including X4 Pharmaceuticals Inc (XFOR) , Genocea Biosciences Inc (GNCAQ) , and Acumen Pharmaceuticals Inc (ABOS) among others .

Click here to see the complete history of Derek M Meisner’s form 4 insider trades.

Insider Ownership Summary of Derek M Meisner

Ticker Comapny Transaction Date Type of Owner
XFOR X4 Pharmaceuticals Inc 2021-08-17 General Counsel
GNCAQ Genocea Biosciences Inc 2018-09-20 SENIOR VP AND GENERAL COUNSEL
ABOS Acumen Pharmaceuticals Inc 2024-01-19 Chief Legal Office & Corp Sec
LIMIT LIMIT 2018-09-20 SENIOR VP AND GENERAL COUNSEL

Derek M Meisner Latest Holdings Summary

Derek M Meisner currently owns a total of 2 stocks. Among these stocks, Derek M Meisner owns 108,867 shares of Acumen Pharmaceuticals Inc (ABOS) as of January 19, 2024, with a value of $326,601 and a weighting of 89.38%. Derek M Meisner also owns 72,730 shares of X4 Pharmaceuticals Inc (XFOR) as of August 17, 2021, with a value of $38,805 and a weighting of 10.62%.

Latest Holdings of Derek M Meisner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABOS Acumen Pharmaceuticals Inc 2024-01-19 108,867 3.00 326,601
XFOR X4 Pharmaceuticals Inc 2021-08-17 72,730 0.53 38,805

Holding Weightings of Derek M Meisner


Derek M Meisner Form 4 Trading Tracker

According to the SEC Form 4 filings, Derek M Meisner has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the sale of 8,933 shares on January 19, 2024, which brought Derek M Meisner around $31,087.

According to the SEC Form 4 filings, Derek M Meisner has made a total of 4 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in X4 Pharmaceuticals Inc is the sale of 8,332 shares on August 17, 2021, which brought Derek M Meisner around $42,493.

Insider Trading History of Derek M Meisner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Derek M Meisner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Derek M Meisner Ownership Network

Ownership Network List of Derek M Meisner

No Data

Ownership Network Relation of Derek M Meisner

Insider Network Chart

Derek M Meisner Owned Company Details

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Derek M Meisner is the General Counsel of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Derek M Meisner made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 601,883 shares made by Paula Ragan , a net sale of 161,480 shares made by Mary Dibiase , and a net sale of 552,345 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 660,362 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 660,362 shares. During the past 18 months, 1,626,785 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,601,785 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

Derek M Meisner Mailing Address

Above is the net worth, insider trading, and ownership report for Derek M Meisner. You might contact Derek M Meisner via mailing address: C/o Genocea Biosciences, Inc., 100 Acorn Park Drive, 5th Floor, Cambridge Ma 02140.